| scholarly article | Q13442814 |
| P356 | DOI | 10.1096/FJ.03-0702FJE |
| P698 | PubMed publication ID | 15033924 |
| P2093 | author name string | Pierre-Louis Tharaux | |
| Christos Chatziantoniou | |||
| Jean-Claude Dussaule | |||
| Sandrine Placier | |||
| Martin Flamant | |||
| Hélène François | |||
| Dominique Chansel | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 926-928 | |
| P577 | publication date | 2004-03-19 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition | |
| P478 | volume | 18 |
| Q33330767 | A stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agents |
| Q54343045 | ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis. |
| Q46616535 | Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach |
| Q28081097 | Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis |
| Q51743726 | Blood HER2 and Uromodulin as Causal Mediators of CKD. |
| Q37061596 | Cardiac toxicity: old and new issues in anti-cancer drugs. |
| Q93203400 | Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and Gefitinib |
| Q28546466 | Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo |
| Q24644250 | Cellular mediators of renal vascular dysfunction in hypertension |
| Q64057204 | Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis |
| Q36223297 | EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy |
| Q64265796 | EGFR drives the progression of AKI to CKD through HIPK2 overexpression |
| Q33779193 | EGFR inhibition attenuates diabetic nephropathy through decreasing ROS and endoplasmic reticulum stress |
| Q37269308 | EGFR mediates hyperlipidemia-induced renal injury via regulating inflammation and oxidative stress: the detrimental role and mechanism of EGFR activation |
| Q26796628 | EGFR signaling in renal fibrosis |
| Q35715849 | EGFR signaling promotes TGFβ-dependent renal fibrosis |
| Q35222407 | Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure |
| Q50925387 | Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis. |
| Q35452282 | Endothelin and the podocyte |
| Q33814199 | Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System |
| Q33646704 | Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy |
| Q27686898 | Epidermal growth factor: a new therapeutic target in glomerular disease |
| Q49553994 | Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabetic Nephropathy. |
| Q39472497 | Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells |
| Q38354523 | Global upregulation of gene expression associated with renal dysfunction in DOCA-salt-induced hypertensive rats occurs via signaling cascades involving epidermal growth factor receptor: a microarray analysis. |
| Q40974170 | Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis |
| Q89355259 | Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes |
| Q35856880 | Integrin alpha1beta1 controls reactive oxygen species synthesis by negatively regulating epidermal growth factor receptor-mediated Rac activation |
| Q40759373 | Integrin alpha1beta1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor gamma-dependent caveolin-1 expression |
| Q30317783 | Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression |
| Q34306057 | Osteopontin overproduction is associated with progression of glomerular fibrosis in a rat model of anti-glomerular basement membrane glomerulonephritis. |
| Q43695348 | Protection from renal fibrosis, putative role of TRIB3 gene silencing |
| Q33495583 | Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin |
| Q36775273 | Reversal of renal disease: is it enough to inhibit the action of angiotensin II? |
| Q53642550 | Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice. |
| Q89799077 | Role of Heparin-Binding Epidermal Growth Factor-Like Growth Factor in Oxidative Stress-Associated Metabolic Diseases |
| Q26743407 | Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis |
| Q40312801 | Role of TGF-alpha in the progression of diabetic kidney disease |
| Q36224457 | Role of epidermal growth factor receptor in acute and chronic kidney injury |
| Q37190266 | Soluble HB-EGF induces epithelial-to-mesenchymal transition in inner medullary collecting duct cells by upregulating Snail-2. |
| Q36986519 | Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury |
| Q37884486 | TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis |
| Q38259755 | Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease. |
| Q39960326 | The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. |
| Q37840243 | The role of cell plasticity in progression and reversal of renal fibrosis |
| Q34213244 | Transforming growth factor alpha is a critical mediator of radiation lung injury |
| Q46521675 | Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib |
Search more.